causal
US market subsidizes global drug innovation
Because U.S. prices are unrestrained while other countries negotiate lower prices, the United States acts as a cash cow whose market profitability drives pharmaceutical innovation for the whole world, and the high entry and compliance barriers prevent the new competitors that high profits would normally attract.
causalpending
Speaker
Russ RobertsEvidence Quote
“the United States as this great cash cow, for pharma, is driving innovation for the whole world”
Created: 6/13/2026, 12:13:30 AM
Your notes
Loading notes...